We are proud to announce our sponsorship of the Roger Davis Award at the upcoming Kern Lipid Conference. The conference, renowned for its focus on cutting-edge lipid research, will take place from 14th to 16th August, 2023 in Colorado, USA.
As part of our commitment to supporting advancements in the field of lipidomics, we have chosen to sponsor the Roger Davis Award, which recognizes outstanding contributions to lipid research. This sponsorship aligns perfectly with Lipotype’s mission to promote scientific innovation and foster collaborations within the lipidomics community.
The recipient of this year’s Roger Davis Award is Dr. Saranna Fanning, Assistant Professor of Neurology at Brigham and Women’s Hospital and Harvard Medical School. Dr. Fanning’s groundbreaking work on aberrant lipid metabolism and its implications in Parkinson’s disease has earned her international recognition. Her expertise in pinpointing rational therapeutic targets and strategies for this debilitating condition makes her a true pioneer in the field.
“We are honored to have Dr. Saranna Fanning as the recipient of the Roger Davis Award this year,” said Prof. Dr. Kai Simons, CEO of Lipotype. “Her exceptional work in lipidomics and its application in Parkinson’s disease represents a significant contribution to the scientific community. We are proud to support her achievements and look forward to her enlightening presentation at the Kern Lipid Conference.”
For additional details regarding Lipotype and its lipid analysis services, feel free to click here. To gather comprehensive information about the Kern Lipid Conference, such as the schedule and program details, please click here. Furthermore, if you’re interested in Dr. Fanning’s work, you can find more information about her and her research here.